E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/30/2006 in the Prospect News Bank Loan Daily and Prospect News Biotech Daily.

Cytyc gets $150 million revolver

By Sara Rosenberg

New York, June 30 - Cytyc Corp. closed on a new $150 million five-year senior unsecured revolving credit facility, according to a company news release.

JPMorgan Chase Bank acted as administrative agent and Bank of America acted as syndication agent. Other lenders in the syndicate include Citizens Bank of Massachusetts, HSBC Bank USA, SunTrust Bank and Wells Fargo Bank.

There is a $150 million accordion feature.

Borrowings will be used for general corporate purposes.

Cytyc is a Marlborough, Mass.-based women's health company that designs, develops, manufactures and markets innovative and clinically effective products for cervical cancer screening, breast cancer risk assessment, treatment of excessive menstrual bleeding and treatment of breast cancer.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.